LAUSR

330 www.ccmjournal.org February 2018 • Volume 46 • Number 2 16. Leguelinel-Blache G, Nugyen TL, Louart B, et al: Impact of a Quality Bundle Enforcement by a Critical Care Pharmacist on Patient Outcome and Costs. Crit Care Med 2018; 46:199–207 17. Marshall J, Finn CA, Theodore AC: Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med 2008; 36:427–433 18. Stollings JL, Foss JJ, Ely EW, et al: Pharmacist leadership in ICU quality improvement: Coordinating spontaneous awakening and breathing trials. Ann Pharmacother 2015; 49:883–891 19. MacLaren R, Brett McQueen R, Campbell J: Clinical and financial impact of pharmacy services in the intensive care unit: Pharmacist and prescriber perceptions. Pharmacotherapy 2013; 33:401–410 20. Chant C, Dewhurst NF, Friedrich JO: Do we need a pharmacist in the ICU? Intensive Care Med 2015; 41:1314–1320 21. Board of Family Specialties: Critical Care Pharmacy. Available at: https://www.bpsweb.org/bps-specialties/critical-care-pharmacy/. Accessed October 22, 2017 22. Pantoja T, Opiyo N, Lewin S, et al: Implementation strategies for health systems in low-income countries: An overview of systematic reviews. Cochrane Database Syst Rev 2017; 12: 9 23. Brummel A, Lustig A, Westrich K, et al: Best practices: Improving patient outcomes and costs in an ACO through comprehensive medication therapy management. J Manag Care Spec Pharm 2014; 20:1152–1158 24. Seneviratne RE, Bradbury H, Bourne RS: How do pharmacists develop into advanced level practitioners? learning from the experiences of critical care pharmacists. Pharmacy (Basel) 2017; 5:E38 25. Society of Critical Care Medicine: Clinical Pharmacy and Pharmacology Section: Guidelines for Governance. Available at: http://www.sccm. org/Member-Center/Sections/Pages/CPP-Section.aspx. Accessed October 22, 2017